Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) today announced that new data on anti-tau antibody etalanetug (development code: E2814) was presented at the 18th Clinical Trials on Alzheimer's ...

Pexels Image by Tom Swinnen Scientists in Jackson may be on their way to finding the cure to Alzheimer's. Researchers at ...

Low blood levels of choline, crucial for liver function and controlling inflammation, could be among the various ways through which obesity can speed up cognitive decline and increase the risk of ...

Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.

We have so many things that we can offer early on. It’s heartbreaking when I see patients that are years into these symptoms ...

Thousands of people have it, and thousands more are impacted by it. We're talking about Alzheimer's disease. But there's hope ...

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

Did you know weak leg muscles accelerate cognitive decline & dementia risk after 40? Learn how to strengthen legs for better ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...

Investing.com -- INmune Bio Inc (NASDAQ:INMB) stock dropped 4.6% Monday following the release of new neuroimaging data from its Phase 2 MINDFuL trial of XPro1595 in patients with early Alzheimer’s ...

Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood ...